| First Author | Kattah MG | Year | 2018 |
| Journal | J Exp Med | Volume | 215 |
| Issue | 7 | Pages | 1839-1852 |
| PubMed ID | 29930103 | Mgi Jnum | J:265681 |
| Mgi Id | MGI:6192948 | Doi | 10.1084/jem.20180198 |
| Citation | Kattah MG, et al. (2018) A20 and ABIN-1 synergistically preserve intestinal epithelial cell survival. J Exp Med 215(7):1839-1852 |
| abstractText | A20 (TNFAIP3) and ABIN-1 (TNIP1) are candidate susceptibility genes for inflammatory bowel disease and other autoimmune or inflammatory diseases, but it is unclear how these proteins interact in vivo to prevent disease. Here we show that intestinal epithelial cell (IEC)-specific deletion of either A20 or ABIN-1 alone leads to negligible IEC loss, whereas simultaneous deletion of both A20 and ABIN-1 leads to rapid IEC death and mouse lethality. Deletion of both A20 and ABIN-1 from enteroids causes spontaneous cell death in the absence of microbes or hematopoietic cells. Studies with enteroids reveal that A20 and ABIN-1 synergistically restrict death by inhibiting TNF-induced caspase 8 activation and RIPK1 kinase activity. Inhibition of RIPK1 kinase activity alone, or caspase inhibition combined with RIPK3 deletion, abrogates IEC death by blocking both apoptosis and necroptosis in A20 and ABIN-1 double-deficient cells. These data show that the disease susceptibility proteins A20 and ABIN-1 synergistically prevent intestinal inflammation by restricting IEC death and preserving tissue integrity. |
